These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8671823)

  • 21. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
    Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
    J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.
    Amann K; Törnig J; Flechtenmacher C; Nabokov A; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Nov; 10(11):2043-8. PubMed ID: 8643165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
    Amann K; Rump LC; Simonaviciene A; Oberhauser V; Wessels S; Orth SR; Gross ML; Koch A; Bielenberg GW; VAN Kats JP; Ehmke H; Mall G; Ritz E
    J Am Soc Nephrol; 2000 Aug; 11(8):1469-1478. PubMed ID: 10906160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].
    Kong WX; Ma J; Gu Y; Yang HC; Zuo YQ; Lin SY
    Zhonghua Nei Ke Za Zhi; 2003 Mar; 42(3):186-90. PubMed ID: 12816702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy.
    Lee GS; Nast CC; Peng SC; Artishevsky A; Ihm CG; Guillermo R; Levin PS; Glassock RJ; LaPage J; Adler SG
    Kidney Int; 1998 May; 53(5):1389-98. PubMed ID: 9573557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
    Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM
    Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J; Odoni G; Ogata H; Viedt C; Amann K; Ritz E; Orth SR
    Nephrol Dial Transplant; 2002 May; 17(5):780-7. PubMed ID: 11981063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis.
    Mercier I; Pham-Dang M; Clement R; Gosselin H; Colombo F; Rouleau JL; Calderone A
    Br J Pharmacol; 2002 Jul; 136(5):685-92. PubMed ID: 12086977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Rowett rat strain is resistant to renal fibrosis.
    Kökény G; Németh Z; Godó M; Hamar P
    Nephrol Dial Transplant; 2010 May; 25(5):1458-62. PubMed ID: 20028828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity.
    Nabokov A; Amann K; Gassmann P; Schwarz U; Orth SR; Ritz E
    Nephrol Dial Transplant; 1998 Jan; 13(1):173-6. PubMed ID: 9481735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism.
    Wolf SC; Sauter G; Rodemann HP; Risler T; Brehm BR
    Nephrol Dial Transplant; 2005 Feb; 20(2):312-8. PubMed ID: 15585510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
    Mackenzie HS; Troy JL; Rennke HG; Brenner BM
    J Hypertens Suppl; 1994 Nov; 12(9):S11-6. PubMed ID: 7884578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiomyocyte loss in experimental renal failure: prevention by ramipril.
    Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G
    Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
    Hofman C; Gabai E; Peleg E; Munter K; Rosenthal T
    Blood Press; 2005; 14(2):114-9. PubMed ID: 16036489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis.
    Nakamura T; Fukui M; Ebihara I; Osada S; Takahashi T; Tomino Y; Koide H
    Clin Sci (Lond); 1995 Jan; 88(1):29-37. PubMed ID: 7704997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
    Yoshida Y; Sakai T; Asakura K; Sugano M; Ise M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1001-8. PubMed ID: 2263021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
    Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E
    Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.